Evidence map›Paper›PMID 37989807›Full record

ArticleCellular and molecular life sciences : CMLS2023

Exploring the link between hedonic overeating and prefrontal cortex dysfunction in the Ts65Dn trisomic mouse model.

Marta Fructuoso, Álvaro Fernández-Blanco, Ana Gallego-Román, Cèsar Sierra, María Martínez de Lagrán, Nicola Lorenzon, Ilario De Toma, Klaus Langohr, Elena Martín-García, Rafael Maldonado and 3 more

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Marta Fructuoso *Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003, Barcelona, Spain.
Álvaro Fernández-Blanco *Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003, Barcelona, Spain.
Ana Gallego-RománLaboratory of Neuropharmacology-Neurophar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Cèsar SierraCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003, Barcelona, Spain.
María Martínez de LagránCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003, Barcelona, Spain.
Nicola LorenzonCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003, Barcelona, Spain.
Ilario De TomaCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003, Barcelona, Spain.
Klaus LangohrHuman Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Program, Hospital Del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain.
Elena Martín-GarcíaLaboratory of Neuropharmacology-Neurophar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Rafael MaldonadoLaboratory of Neuropharmacology-Neurophar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Julien DairouDepartament de Psicobiologia i Metodologia de Les Ciències de la Salut, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès, Barcelona, Spain.
Nathalie JanelBFA, UMR 8251, CNRS, Université de Paris, 75013, Paris, France.
Mara DierssenCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003, Barcelona, Spain. mara.dierssen@crg.eu.ORCID http://orcid.org/0000-0003-0853-6865
Centre for Genomic Regulation · ESUniversitat Pompeu Fabra · ESUniversitat Autònoma de Barcelona · ESCentre National de la Recherche Scientifique · FRHospital Del Mar · ES

Funding

New methods and theories to interrogate organizational principles from single cell to neuronal networksR01EB028159 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DIERSSEN, MARA, YE, BING · 2019 to 2019
$951k
Fondation Jérôme Lejeune 2002Fundació la Marató de TV3 201620-31H2020 Excellent Science 848077Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España PID2019-110755RB-I00/AEI/10.13039/501100011033Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España RTC2019-007230-1Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España RTC2019-007329-1NIBIB NIH HHS R01 EB028159NIH Blueprint for Neuroscience Research 1R01EB 028159-01Plan Nacional sobre Drogas PNSD-2019I006
6 · The paper itself

Abstract

Individuals with Down syndrome (DS) have a higher prevalence of obesity compared to the general population. Conventionally, this has been attributed to endocrine issues and lack of exercise. However, deficits in neural reward responses and dopaminergic disturbances in DS may be contributing factors. To investigate this, we focused on a mouse model (Ts65Dn) bearing some triplicated genes homologous to trisomy 21. Through detailed meal pattern analysis in male Ts65Dn mice, we observed an increased preference for energy-dense food, pointing towards a potential "hedonic" overeating behavior. Moreover, trisomic mice exhibited higher scores in compulsivity and inflexibility tests when limited access to energy-dense food and quinine hydrochloride adulteration were introduced, compared to euploid controls. Interestingly, when we activated prelimbic-to-nucleus accumbens projections in Ts65Dn male mice using a chemogenetic approach, impulsive and compulsive behaviors significantly decreased, shedding light on a promising intervention avenue. Our findings uncover a novel mechanism behind the vulnerability to overeating and offer potential new pathways for tackling obesity through innovative interventions.

Indexed as

Down SyndromeTrisomyAnimalsDisease Models, AnimalHumansHyperphagiaMaleMiceObesityPrefrontal CortexDopamineDown syndromeObesityOvereatingPrefrontal cortex

Identifiers

PMID37989807
PMCPMC11072570
OpenAlexW4388853773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.